Sort by
Medicine and Dentistry
Adiponectin
9%
Adult
9%
Aging
9%
Alanine Aminotransferase
10%
Antivirus Agent
16%
Cell Activity
9%
Chronic Hepatitis
13%
Chronic Hepatitis C
53%
COVID-19
9%
Decompensated Liver Cirrhosis
9%
Development
22%
Dicer
9%
Echography
11%
Fibrosis
15%
Hepatitis C
15%
Hepatitis C Virus
23%
Hepatocellular Carcinoma
100%
Hepatoma Cell
9%
Image Analysis
9%
Inpatient
43%
Integrin
9%
Isoenzyme
9%
Lenvatinib
9%
Lesion
11%
Liver
40%
Liver Biopsy
12%
Liver Cirrhosis
12%
Liver Development
9%
Liver Disease
12%
Liver Fibrosis
15%
Measurement
17%
Mechanism of Action
9%
microRNA 221
9%
Mortality
13%
Neoplasm
11%
Nonalcoholic Fatty Liver
9%
Obesity
11%
Outpatient
11%
Patient
79%
Perfluorobutane
19%
Radiofrequency Ablation
29%
Regeneration
9%
Regorafenib
9%
Risk Assessment
19%
Scar Formation
9%
Screening
15%
Serum
11%
Surveillance
27%
Therapeutic Procedure
27%
Transient Elastography
39%
Pharmacology, Toxicology and Pharmaceutical Science
Acute on Chronic Liver Failure
9%
Adiponectin
9%
Alpha2a Interferon
9%
Antiviral Therapy
9%
Autotaxin
9%
Bone Morphogenetic Protein
9%
Bone Morphogenetic Protein Receptor 1A
9%
Cell Culture
9%
Chronic Hepatitis
12%
Chronic Liver Disease
13%
Dicer
9%
Diethylnitrosamine
9%
Drug Screening
9%
Elbasvir
9%
Fat
9%
Fibrosis
9%
Fluorouracil
9%
Glecaprevir
9%
Grazoprevir
9%
Hepatitis
9%
Hepatitis A Virus
9%
Hepatitis B Virus
9%
Hepatitis C Virus
23%
Hepatitis C Virus Genotype 1
9%
Hepatitis C Virus Genotype 4
9%
Infection
9%
Interferon
12%
Interleukin 6
9%
Kidney Polycystic Disease
9%
Liver Cancer
12%
Liver Carcinogenesis
9%
Liver Cell Carcinoma
56%
Liver Cirrhosis
10%
Liver Fibrosis
9%
Lymphadenopathy
9%
microRNA 221
9%
Mitogen Activated Protein Kinase Kinase 3
9%
Nicotinamide
9%
Nonalcoholic Fatty Liver
9%
Peginterferon
9%
Peginterferon Alpha
9%
Perflubutane
9%
Pibrentasvir
9%
Recurrent Disease
24%
Regorafenib
9%
Ribavirin
9%
Suppressor of Cytokine Signaling 2
9%
Tolvaptan
9%
Virus DNA
9%
Zinc Acetate
9%
Biochemistry, Genetics and Molecular Biology
Adiponectin
9%
Alpha-Fetoprotein
10%
Autotaxin
9%
Cancer Staging
5%
Cell Activity
9%
Classification
7%
Creatine Kinase
9%
Cytokine
9%
Cytometry
9%
Development
12%
Disintegrin
9%
Drug Screening
9%
Elastography
21%
Hepatitis A Virus
9%
Hepatitis A Virus
9%
Hepatitis C Virus
16%
Hepatitis C Virus Genotype 1
9%
Hepatocyte
8%
Incidence
8%
Interferon
21%
Interleukin 6
9%
Isoenzyme
9%
Liver Regeneration
9%
Matrix Metalloproteinase
9%
Metabolic Balance
9%
Metalloproteinase
9%
Mitogen-Activated Protein Kinase
9%
Nicotinamide
9%
Radiofrequency
9%
Regorafenib
9%
Ribavirin
9%
Rigidity
29%
Sample
5%
Screening
6%
Sex Difference
9%
Single-Cell Analysis
9%
Survival
6%
Thrombospondin
9%
Time
7%
Tissue Inhibitor of Metalloproteinase
9%
Training
9%
Tumor Marker
5%
Tumor Necrosis Factor Alpha
9%
Tumor Volume
5%
Ultrasonography
14%
Ultrasound
9%
Virus Load
6%
